Division of Allergy Pulmonary and Critical Care Medicine Archive — Page 1 of 12

(courtesy of the CDC)
July 15, 2026

Vanderbilt Health physicians treating more patients with tick bites this year

Six medically important tick species live in the state, and many Tennesseans encounter ticks in their own yard or neighborhood. Perhaps attributable to changing weather patterns and rising temperatures, Vanderbilt Health’s Emergency Medicine physicians around the region began treating patients with tick bites in March this year.

July 9, 2026

Bronchiectasis Day gathering at Langford Auditorium

The Vanderbilt Health NTM and Bronchiectasis Center, a program of the Vanderbilt Lung Institute, launched in 2023. The chronic lung disease is estimated to affect 350,000 to 500,000 adults in the United States.

(iStock)
June 1, 2026

Vanderbilt Health study explores GLP-1 therapies to improve asthma outcomes in patients with obesity  

The study is still recruiting participants. It will conclude in 2026 and provide insight for further investigations into the role GLP-1 agonists may offer in treating respiratory illnesses and overall immune responses.

April 9, 2026

How robotic bronchoscopy helped a Georgia man avoid unnecessary lung surgery

Oncologist Mohamed Shanshal, MD, said robotic bronchoscopy significantly improves getting patients the appropriate treatment as soon as possible, reducing their anxiety and improving care.

Jonathan Kropski, MD
March 13, 2026

Jonathan Kropski appointed director of Allergy, Pulmonary and Critical Care Medicine

Kropski is a physician-scientist whose research has helped advance the understanding and potential treatment of interstitial lung disease.

Members of the Vanderbilt Health team are evaluating the efficacy of the immunomodulatory drug baricitinib for treating the persistent neurological and cardiopulmonary symptoms of long COVID. (photo by Donn Jones)
February 6, 2026

Vanderbilt Health to lead expanded multisite study of immunomodulation in long COVID

The public health burden of long COVID is estimated to be the largest seen from an emerging disease in the past century, yet there remain no effective interventions.